{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:02:07Z","timestamp":1793422927772,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009802","name":"Stiftelsen S\u00f6derstr\u00f6m K\u00f6nigska Sjukhemmet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bbi.2024.02.029","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T16:39:13Z","timestamp":1709311153000},"page":"192-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Omega-3 fatty acids for inflamed depression \u2013 A match\/mismatch study"],"prefix":"10.1016","volume":"118","author":[{"given":"Klara","family":"Suneson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"S\u00f6derberg Veib\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Tjernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"St\u00e5hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ventorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"\u00c4ngeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Lundblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen M.","family":"Wolkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-327X","authenticated-orcid":false,"given":"Daniel","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbi.2024.02.029_b0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/1028415X.2019.1659560","article-title":"Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review","volume":"24","author":"AlAmmar","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbi.2024.02.029_b0010","article-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"APA","year":"2013","journal-title":"American Psychiatric Publications"},{"key":"10.1016\/j.bbi.2024.02.029_b0015","doi-asserted-by":"crossref","unstructured":"Appleton, K.M., Voyias, P.D., Sallis, H.M., Dawson, S., Ness, A.R., Churchill, R., et al., 2021. Omega-3 fatty acids for depression in adults. Cochrane Database Syst. Rev. 11, CD004692.","DOI":"10.1002\/14651858.CD004692.pub5"},{"issue":"4","key":"10.1016\/j.bbi.2024.02.029_b0020","first-page":"652","article-title":"Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood","volume":"10","author":"Aziz","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2024.02.029_b0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the insomnia severity index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med."},{"issue":"12","key":"10.1016\/j.bbi.2024.02.029_b0030","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/mp.2011.100","article-title":"Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis","volume":"17","author":"Bloch","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hup.2526","volume":"31","author":"Bobo","year":"2016","journal-title":"Hum. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2024.02.029_b0040","doi-asserted-by":"crossref","first-page":"e60759","DOI":"10.1371\/journal.pone.0060759","article-title":"Time variability of C-reactive protein: implications for clinical risk stratification","volume":"8","author":"Bogaty","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbi.2024.02.029_b0045","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1038\/s41380-021-01160-8","article-title":"Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis","volume":"26","author":"Borsini","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2024.02.029_b0050","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"6 Suppl","key":"10.1016\/j.bbi.2024.02.029_b0055","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2024.02.029_b0065","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/npp.2016.123","article-title":"Role of adiposity-driven inflammation in depressive morbidity","volume":"42","author":"Capuron","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.jrn.2019.06.007","article-title":"The effect of omega-3 supplementation on serum levels of inflammatory biomarkers and albumin in hemodialysis patients: a systematic review and meta-analysis","volume":"30","author":"Dezfouli","year":"2020","journal-title":"J. Ren. Nutr."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine","volume":"21","author":"Drevets","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2024.02.029_b0090","doi-asserted-by":"crossref","first-page":"1051418","DOI":"10.3389\/fnut.2022.1051418","article-title":"Omega 3 supplementation reduces C-reactive protein, prostaglandin E(2) and the granulocyte\/lymphocyte ratio in heavy smokers: an open-label randomized crossover trial","volume":"9","author":"Elisia","year":"2022","journal-title":"Front. Nutr."},{"issue":"10","key":"10.1016\/j.bbi.2024.02.029_b0095","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2024.02.029_b0100","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","article-title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","volume":"25","author":"Felger","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2024.02.029_b0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40266-021-00858-2","article-title":"Major depressive disorder in older patients as an inflammatory disorder: implications for the pharmacological management of geriatric depression","volume":"38","author":"Forbes","year":"2021","journal-title":"Drugs Aging"},{"issue":"12","key":"10.1016\/j.bbi.2024.02.029_b0110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1176\/appi.ajp.2021.20121776","article-title":"Association between systemic inflammation and individual symptoms of depression: a pooled analysis of 15 population-based cohort studies","volume":"178","author":"Frank","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2024.02.029_b0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41398-022-01900-6","article-title":"Developing symptom clusters: linking inflammatory biomarkers to depressive symptom profiles","volume":"12","author":"Franklyn","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"16","key":"10.1016\/j.bbi.2024.02.029_b0125","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1017\/S0033291719002770","article-title":"Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates","volume":"50","author":"Fried","year":"2020","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0269881120981392","article-title":"Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: a meta-analysis of randomized controlled trials","volume":"35","author":"Goh","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2024.02.029_b0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000502652","article-title":"International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder","volume":"88","author":"Guu","year":"2019","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.bbi.2024.02.029_b0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2024.02.029_b0145","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/mp.2015.206","article-title":"Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression","volume":"21","author":"Haroon","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2024.02.029_b0150","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2024.02.029_b0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bmjebm-2020-111600","article-title":"Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression","volume":"27","author":"Hengartner","year":"2022","journal-title":"BMJ Evid Based Med."},{"issue":"5","key":"10.1016\/j.bbi.2024.02.029_b0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbalip.2017.02.010","article-title":"Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways","volume":"1862","author":"Inoue","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbi.2024.02.029_b0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamapsychiatry.2015.1977","article-title":"Inflammation and specific symptoms of depression","volume":"73","author":"Jokela","year":"2016","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0175","first-page":"42","article-title":"Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease","volume":"37","author":"Koc","year":"2010","journal-title":"Tex. Heart Inst. J."},{"issue":"9","key":"10.1016\/j.bbi.2024.02.029_b0180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.bbi.2024.02.029_b0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","article-title":"Efficacy of omega-3 PUFAs in depression: a meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2024.02.029_b0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson's disease\u2013associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2024.02.029_b0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.biopsych.2006.02.016","article-title":"The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study","volume":"60","author":"Liukkonen","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2024.02.029_b0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2019.11.017","article-title":"Peripheral blood cell-stratified subgroups of inflamed depression","volume":"88","author":"Lynall","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2024.02.029_b0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbi.2017.01.011","article-title":"The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis","volume":"64","author":"Marsland","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2024.02.029_b0215","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA Psychiat."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0220","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinchem\/47.3.426","article-title":"Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects","volume":"47","author":"Meier-Ewert","year":"2001","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0225","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/npp.2016.167","article-title":"Therapeutic implications of brain-immune interactions: treatment in translation","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.bbi.2024.02.029_b0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2215-0366(20)30357-6","article-title":"Trial failures of anti-inflammatory drugs in depression","volume":"7","author":"Miller","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2024.02.029_b0235","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14074","article-title":"Omega-3 fatty acids for major depressive disorder with high inflammation: a randomized dose-finding clinical trial","volume":"83","author":"Mischoulon","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0240","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2024.02.029_b0245","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0891-5849(03)00407-6","article-title":"Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects","volume":"35","author":"Mori","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0250","first-page":"59","article-title":"The effect of omega-3 fatty acids on serum apelin levels in cardiovascular disease: a randomized, double-blind, placebo-controlled trial","volume":"7","author":"Mortazavi","year":"2018","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0255","doi-asserted-by":"crossref","first-page":"18867","DOI":"10.1038\/s41598-019-54535-x","article-title":"Omega-3 fatty acids effects on inflammatory biomarkers and lipid profiles among diabetic and cardiovascular disease patients: a systematic review and meta-analysis","volume":"9","author":"Natto","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbi.2024.02.029_b0260","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-020-00948-6","article-title":"Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial","volume":"46","author":"Nettis","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.bbi.2024.02.029_b0265","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2024.02.029_b0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2022.06.080","article-title":"C-reactive protein could predict the efficacy of SSRIs in clinical practice: a cohort study of large samples in the real world","volume":"313","author":"Pan","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0275","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bbi.2024.02.029_b0280","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1176\/appi.ajp.2020.20060947","article-title":"Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK biobank","volume":"178","author":"Pitharouli","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2024.02.029_b0285","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","article-title":"Is depression an inflammatory disorder?","volume":"13","author":"Raison","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0300","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbi.2024.02.029_b0305","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2147\/NDT.S305331","article-title":"Clinically significant changes in the 17- and 6-item Hamilton rating scales for depression: a STAR*D report","volume":"17","author":"Rush","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41398-023-02438-x","article-title":"Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study","volume":"13","author":"Sforzini","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13075-022-02781-2","article-title":"Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis","volume":"24","author":"Sigaux","year":"2022","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0320","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of hedonic tone the snaith-Hamilton pleasure scale","volume":"167","author":"Snaith","year":"1995","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2024.02.029_b0325","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.bbi.2024.02.029_b0330","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.bbi.2024.02.029_b0335","doi-asserted-by":"crossref","first-page":"e1476","DOI":"10.4088\/JCP.15l10011","article-title":"Personalized medicine with Omega-3 fatty acids for depression in children and pregnant women and depression associated with inflammation","volume":"76","author":"Su","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2024.02.029_b0340","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.biopsych.2014.01.008","article-title":"Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial","volume":"76","author":"Su","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2024.02.029_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041640","article-title":"Inflammatory depression-mechanisms and non-pharmacological interventions","volume":"22","author":"Suneson","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0350","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s12888-022-04430-z","article-title":"Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trial","volume":"22","author":"Suneson","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2024.02.029_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110763","article-title":"An inflamed subtype of difficult-to-treat depression","volume":"125","author":"Suneson","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.02.029_b0360","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.1994.tb01480.x","article-title":"A new self-rating scale for depression and anxiety states based on the comprehensive psychopathological rating scale","volume":"89","author":"Svanborg","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.bbi.2024.02.029_b0365","first-page":"500","article-title":"Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients","volume":"23","author":"Tayyebi-Khosroshahi","year":"2012","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/j.bbi.2024.02.029_b0370","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbi.2023.03.031","article-title":"Sickness behaviour and depression: an updated model of peripheral-central immunity interactions","volume":"111","author":"Turkheimer","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.bbi.2024.02.029_b0375","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2024.02.029_b0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2016.08.012","article-title":"Association of inflammation with specific symptoms of depression in a general population of older people: the english longitudinal study of ageing","volume":"61","author":"White","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2024.02.029_b0385","article-title":"Towards a multidimensional model of inflamed depression","volume":"26","author":"Wijaya","year":"2022","journal-title":"Brain Behav Immun Health."},{"issue":"2","key":"10.1016\/j.bbi.2024.02.029_b0390","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"6","key":"10.1016\/j.bbi.2024.02.029_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13061003","article-title":"Personalized medicine of Omega-3 fatty acids in depression treatment in obese and metabolically dysregulated patients","volume":"13","author":"Wu","year":"2023","journal-title":"J Pers Med."},{"key":"10.1016\/j.bbi.2024.02.029_b0400","first-page":"72","article-title":"Is there Progress? an overview of selecting biomarker candidates for major depressive disorder","volume":"7","author":"Young","year":"2016","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2024.02.029_b0405","article-title":"Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Psych."}],"updated-by":[{"DOI":"10.1016\/j.bbi.2025.02.021","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T03:07:40Z","timestamp":1742180860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":81,"alternative-id":["S0889159124002733"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.02.029","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bbi.2025.02.021","asserted-by":"object"}]},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 fatty acids for inflamed depression \u2013 A match\/mismatch study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}